TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
OBIO

Orchestra BioMed Holdings Inc.

Healthcare · Biotechnology

6.10$ +5.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Orchestra BioMed Holdings Inc. (OBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -49 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow OBIO
Line item 2020 2021 2022 2023 2024 2025
-26 -19 -29 -46 -51 -49
0.1 0.2 0.2 0.3 0.3 0.3
0.2 0.3 3.4 7.6 11 12
3.2 0.6
-8.1 2.6 -0.5 -3.3 -0.8 -10
0.5 0.3 0.6 0.1 0.3 0.5
27 13 -64 11 13 -27
-93
10 -4.0 3.6 -11 15 0.0
10 -4.0 103 46 29 88
11 -10 9.8 11 -8.3 12
-27 -20 -30 -46 -51 -49

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?